IN
InMed Pharmaceuticals Inc.
INM · NASDAQ
$1.39 -5.12% (-$0.08)
1M -11.11%
Market Cap $2.32M
P/E Ratio 0.00x
Div. Yield -
ROE 191.57%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.00x
P/B 0.00x
P/E 0.00x
Growth
100 /100
Growing Book val. growth 306.40%
Rev. growth 815.81%
FCF growth N/A
Profitability
53 /100
Moderate Net margin 25.83%
Op. margin 25.20%
FCF margin 341.77%
Quality
94 /100
Excellent ROE 191.57%
ROA 17.56%
Asset turnover 0.68x
Debt
93 /100
Low Current ratio 1.37x
Net debt/EBITDA -4.68x
Debt/Equity 0.00x
Stability
48 /100
Moderate Rev. volatility 37,041.61%
EPS volatility 21.58%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre INM
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Eric A. Adams Chem.
Employees
13
Headquarters
Vancouver
Evenimente viitoare
23 SEPT.
Earnings
Upcoming earnings report
05 NOV.
Earnings
Upcoming earnings report